Pfizer Expands Cost-Cutting Initiative to $6.5 Billion Amidst Post-Pandemic Revenue Adjustments and Pipeline Challenges
admin New York, NY – August 4, 2026 – Pfizer Inc. today announced a significant expansion...
Biotech, Pharma & Cancer Drug Development
Vertex Pharmaceuticals Navigates Robust Financial Growth Amidst Emerging Competitive Threats in Cystic Fibrosis Market
Vertex Pharmaceuticals, a titan in the biotechnology sector, recently reported stellar financial results for the...
Resilience and Lilly invest $750M to boost Cincinnati drug production
In a significant move to bolster the production of critical GLP-1 injectable medications, contract manufacturer...
Supernus Pharmaceuticals to Acquire Indivior in a Strategic Merger Creating a Diversified Neurological and Psychiatric Powerhouse
In a significant move poised to reshape the specialty pharmaceutical landscape, Supernus Pharmaceuticals has announced...
BioNTech Appoints Guido Oelkers as New CEO, Solidifying Oncology Re-focus as Co-Founders Depart for New mRNA Venture
BioNTech, the German biotechnology firm that rose to global prominence for its pioneering COVID-19 vaccine,...
AstraZeneca and Bristol Myers Squibb Megamerger Rumors Trigger Market Turmoil and Industry Rethink
Rumors of a potential megamerger between pharmaceutical giants AstraZeneca and Bristol Myers Squibb have sent...
Trump administration tries again to institute rebates in 340B
The Trump administration has once again initiated a pilot program aimed at implementing rebates within...
Sanofi Seeks to Reinvigorate Regeneron Alliance Amid Strategic Reshuffle, While BMS Faces Pipeline Delays and Apnimed’s IPO Signals Biotech Resilience
A dynamic week in the biopharmaceutical sector saw Sanofi’s new leadership publicly commit to mending...
Ziltivekimab’s Phase 3 Failure Shatters Hopes for Inflammation-Targeting Cardiovascular Drugs, Triggering Widespread Biotech Market Decline.
The biopharmaceutical sector was rocked on July 31, 2026, as Novo Nordisk announced the disappointing...
Johnson & Johnson Secures Option to Acquire Sail Biomedicines, Marking Major Bet on In Vivo CAR-T for Autoimmune Diseases
Pharmaceutical giant Johnson & Johnson has taken a significant step into the burgeoning field of...
